<img height="1" width="1" src="https://www.facebook.com/tr?id=914352225269004&amp;ev=PageView &amp;noscript=1">
HubSpot Video
Brand New Medical Study

A Potential Treatment for Women Concerned about Low Libido

💡 No overnight stays

Click here or scroll down to learn about this study's inclusion criteria ⬇️

By signing up to Evrima Connect, you consent to Evrima Technologies' Terms of Service and Privacy Policy.

If you take part in the research study you will receive:

No overnight stays!

All study visits are out-patient only.

Advance Medical Science

Do your part to help advance breakthroughs in clinical research.

🏥 Study Guide

To learn more about this study and what participation might mean for you, please watch the video below (the video is subtitled if you wish to watch it on mute):

HubSpot Video


What is low libido?

Low libido is when there is a decreased interest in sexual activity and/or reduced desire for sex. Low libido can be experienced by both men and women. When a person has low libido or sexual desire and is bothered by this lack of interest, they may have a condition called Hypoactive Sexual Desire Disorder (HSDD). Many women will experience low libido at some time in their lives and an Australian study in 2017 found that this could be as many as 70% of women[3].

It is estimated that 1-in-10 premenopausal women are affected by HSDD[1], where HSDD can be defined as an absence of sexual fantasies and desire for sexual activity causing emotional distress or relationship troubles.

This study is exploring a new treatment for women who are bothered by their low libido.

Who can take part in this study?

In order to be eligible to participate in the study, you must meet all of the following:

  • You are a pre-menopausal female in a stable relationship for at least 1 year
  • You are bothered by your low libido, low sex drive or have been diagnosed HSDD
  • You are aged 21 to 50 years old (inclusive)
  • You have a body mass index (BMI) of less than 38 (BMI calculator)
  • You are able to attend clinic visits 5 times over a 16 week period
  • You are prepared to use a reliable method of contraception if you are in a heterosexual relationship

Who is unable to take part in this study?

Unfortunately, if you meet any of the following, this study is not the right fit for you:

  • Anyone who had ever experienced severe hypersensitivity to drugs
  • Anyone who is pregnant, breastfeeding or has given birth in the last 12 months
  • Anyone who has uncontrolled high blood pressure and/or uncontrolled diabetes

How long will the study take?

A total of 476 participants are invited to this study which will run for a total of 16 weeks. Participants will undergo a screening period of 4 weeks. They will then be asked to self-administer the spray on a daily basis for 4-weeks, followed by an 8-week follow-up period.

Eligible participants will be required to do 5 clinic visits, 5 phone calls and complete some questions on an app once a day during the study. All study medication, tests and medical care required for this clinical trial will be provided to you free of charge. Eligible participants will also be reimbursed for any reasonable study-related expenses.

What is the purpose of this study?

As female sexual dysfunction impacts wellbeing, quality of life and partner relationships[2][3] there is a growing need for a safe, effective and accessible treatment in addition to existing therapies.

This clinical study aims to demonstrate the efficacy of a nasal spray as a potential treatment option for women with Hypoactive Sexual Desire Disorder. It will take place at multiple study sites across Australia and New Zealand.

Where is my nearest study site?

Here is a list of all of the sites who are currently recruiting for this study:



  • Bruce - Paratus Clinical Research Canberra


  • Sydney- Women's Health & Research Institute of Australia
  • Blacktown- Paratus Clinical Research Western Sydney
  • Kanwal- Paratus Clinical Research Central Coast


  • Kent Town- Advanced Gynaecological Surgery Centre


  • Albion- Paratus Clinical Research Brisbane
  • Taringa - Aus Trials
  • Tarragindi - Aus Trials 


  • Melbourne- Monash University Women's Health Research Program (3004)

New Zealand

  • Auckland- Optimal Clinical Trials
  • Christchurch - Southern Clinical Trials


What if I have other questions about the study?

We are here for you! Click or tap this button to send an email to our Patient Experience team:

By signing up to Evrima Connect, you consent to Evrima Technologies' Terms of Service and Privacy Policy.


[1] Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol. 2008; 112(5):970-978.

[2] Rosen NO, Dube JP, Corsini-Munt S, Muise A. Partners Experience Consequences, Too: A Comparison of the Sexual, Relational, and Psychological Adjustment of Women with Sexual Interest/Arousal Disorder and Their Partners to Control Couples. J Sex Med. 2019; 16(1): 83-95.

[3] Biddle AK, West SL, D'Aloisio AA, Wheeler SB, Borisov NN, Thorp J. Hypoactive Sexual Desire Disorder in Postmenopausal Women: Quality of Life and Health Burden. Value Health. 2009; 12(9): 763-772.